Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) accumulation in tumours has been well investigated, but much less is known regarding FDG accumulation in inflammatory lesions. In this study, we determined the effects of hypo- and hyperglycaemia on FDG uptake in inflammatory lesions of infectious and non-infectious origin and compared them with those in malignant tumours in rats, to provide a biological basis for differentiating malignant lesions from benign lesions by means of FDG-PET. Rats were inoculated with a suspension of allogenic hepatoma cells (KDH-8) or Staphylococcus aureus, or with turpentine oil into the left calf muscle. Two weeks after KDH-8 inoculation and 1 week after S. aureus and turpentine oil inoculations, the rats were divided into three subgroups: insulin-loaded (2 U/kg body weight, i.p.), glucose-loaded (1.2 g/kg body weight, p.o.) and control groups. Radioactivity in tissues was determined 1 h after i.v. injection of FDG. Intraperitoneal injection of insulin and oral administration of glucose induced hypoglycaemia and hyperglycaemia, respectively. In the control animals, tumours showed a level of FDG uptake which was 2.2 and 3.0 times higher than the levels in the inflammatory lesions induced by S. aureus and turpentine oil, respectively (P<0.0001). There was no significant difference in the level of FDG uptake between the two inflammatory lesions of infectious and non-infectious origin. Insulin loading significantly decreased the level of FDG uptake in tumours and in both types of inflammatory lesion to approximately one-half of the control values (P=0.001 in the tumour group and P<0.0001 in the two inflammatory lesion groups). In the glucose-loaded group, the level of FDG uptake in both types of inflammatory lesion decreased significantly to 50%-61% of the control value (P=0.0002 in the S. aureus group and P<0.0001 in the turpetine group), while the tumour uptake did not decrease significantly (86% of the control value) (P=NS). It is concluded that FDG uptake in both types of inflammatory lesion was significantly impaired in rats with hyperglycaemia induced by glucose loading, while tumour uptake of FDG was not significantly affected. These results indicate that glucose loading has greater effects on FDG uptake in inflammatory lesions than in tumours, providing a biological basis for differentiation of malignant lesions from benign lesions by FDG-PET in a clinical setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, unnecessary interventions aimed at lowering the BGL are time-and resources-consuming, including insulin injection, which may also increase background FDG uptake and therefore decrease PET scan sensitivity [42].”
In the citing paper
“or the possibility of insulin-induced FDG shunting from tumors to muscles, thus decreasing tumor to background FDG uptake ratio [42,112,113].”
In the citing paper
“This approach may lead to increased costs, inconvenience for patients, unnecessary postponing of PET scan, and delays in diagnosis of potential malignancies”
Citations
Cites
Flier, J. S., Mueckler, M. M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 786 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [1, 2, 3, 4, 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisati…”
BackgroundWahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., Oster, Z. H., Sacker, D. F., Shiue, C. Y., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [ 1 , 2, 3, 4, 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisa…”
Background(1995) · PubMed · Cited by 474
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1557 · Cited by 459 · cited 1×
“It is well known that glucose uptake in peripheral tissues is impaired in infectious diseases owing to peripheral insulin resistance mediated by Glut-4 transporter [31, 32 ].”
BackgroundWahl, R. L., Cody, R. L., Hutchins, G. D., & Mudgett, E. E. (1991) · Radiology · doi:10.1148/radiology.179.3.2027989 · Cited by 431
Wahl, R. L., Quint, L. E., Greenough, R. L., Meyer, C. R., White, R. I., & Orringer, M. B. (1994) · Radiology · doi:10.1148/radiology.191.2.8153308 · Cited by 430
(1993) · PubMed · Cited by 398
Steinert, H. C., Hauser, M., Allemann, F., Engel, H., Berthold, T., von Schulthess, G. K., & Weder, W. (1997) · Radiology · doi:10.1148/radiology.202.2.9015071 · Cited by 376
Differential diagnosis of lung tumor with positron emission tomography: A prospective study
(1991) · Lung Cancer · doi:10.1016/0169-5002(91)90324-y · Cited by 321
Cited by
Zhuang, H., & Alavi, A. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29278 · Cited by 524
18F-FDG PET and PET/CT in fever of unknown origin.
Meller, J., Sahlmann, C., & Scheel, A. (2007) · PubMed · Cited by 323
on behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM), Bucerius, J., Hyafil, F., Verberne, H. J., Slart, R. H. J. A., Lindner, O., Sciagra, R., Agostini, D., Übleis, C., Gimelli, A., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3259-3 · Cited by 257
“tious lesions [27, 28].”
Positron emission tomography imaging in nonmalignant thoracic disorders
Alavi, A., Gupta, N., Alberini, J.-L., Hickeson, M., Adam, L.-E., Bhargava, P., & Zhuang, H. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.127291 · Cited by 218
De Winter, F., Vogelaers, D., Gemmel, F., & Dierckx, R. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0708-2 · Cited by 195
Belhocine, T., Blockmans, D., Hustinx, R., Vandevivere, J., & Mortelmans, L. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1209-y · Cited by 185
Zhao, S., Kuge, Y., Mochizuki, T., Takahashi, T., Nakada, K., Sato, M., Takei, T., & Tamaki, N. (2005) · PubMed · Cited by 175
Self-citationChen, J., Zhao, S., Nakada, K., Kuge, Y., Tamaki, N., Okada, F., Wang, J., Shindo, M., Higashino, F., Takeda, K., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63924-7 · Cited by 170
Self-citationRabkin, Z., Israel, O., & Keidar, Z. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.074294 · Cited by 142
“That model suggested that 18F-FDG uptake in inflammatory lesions was significantly impaired with hyperglycemia, and tumor uptake of 18F-FDG was not significantly affected (20).”
BackgroundLimitations of PET for imaging lymphoma
Barrington, S. F., & O'Doherty, M. J. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1169-2 · Cited by 136
“With moderate hyperglycaemia, however, the uptake of FDG into tumours appears to be relatively unaffected, although uptake into inflammatory lesions and normal tissues is impaired [ 27 ].”
BackgroundBucerius, J. A., Mani, V., Moncrieff, C. B., Macháč, J., Fuster, V., Farkouh, M. E., Tawakol, A. A., Rudd, J. H. F., & Fayad, Z. A. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2569-6 · Cited by 132
“0 mmol/l) but also decreased GLUT-1 and GLUT-3 levels on glucose loading in lesions of infectious origin [29, 30].”
BackgroundBüsing, K. A., Schönberg, S. O., Brade, J., & Wasser, K. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.10.014 · Cited by 111
“Consequently, some investigators described a generally impaired image quality with increasedmuscular tracer uptake after insulin treatment [9,17].”
BackgroundUptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro
Deichen, J. T., Prante, O., Gack, M. U., Schmiedehausen, K., & Kuwert, T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1018-8 · Cited by 120
“The dependence of [18F]FDG uptake on glucose concentration has also been reported in experimental models of inflammation [ 21 ].”
Eskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109
FDG-PET: procedure guidelines for tumour imaging
Bombardieri, E., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Buscombe, J. R., Chatal, J. F., Maffioli, L. S., Moncayo, R., Mortelmans, L., & Reske, S. N. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1355-2 · Cited by 94
Mochizuki, T., Kuge, Y., Zhao, S., Tsukamoto, E., Hosokawa, M., Strausś, H. W., Blankenberg, F. G., Tait, J. F., & Tamaki, N. (2003) · PubMed · Cited by 84
Self-citationImpact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
Roy, F.-N., Beaulieu, S., Boucher, L., Bourdeau, I., & Cohade, C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056283 · Cited by 63
“For others, glucose loading has greater effects on 18F-FDG uptake in inflammatory lesions than in tumors (17).”
BackgroundProliferation Markers for the Differential Diagnosis of Tumor and Inflammation
van Waarde, A., & Elsinga, P. H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549399 · Cited by 64
“(glucose loading [20], steroid treatment [19, 21, 22]), im-”
Zhao, S., Kuge, Y., Kohanawa, M., Takahashi, T., Zhao, Y., Yi, M., Kanegae, K., Seki, K., & Tamaki, N. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.044578 · Cited by 55
“The lesion (tumor, granuloma, or turpentine-induced inflammatory tissue)-to-muscle (L/M) ratios and the lesion-to-blood (L/B) ratios of 18F-FDG, 3H-FLT, and 14C-methionine uptake were calculated from the DUR value of each tissue (18,19).”
MethodSelf-citationZhao, S., Kuge, Y., Tsukamoto, E., Mochizuki, T., Kato, T., HIKOSAKA, K., Nakada, K., Hosokawa, M., Kohanawa, M., & Tamaki, N. (2002) · Nuclear Medicine Communications · doi:10.1097/00006231-200206000-00006 · Cited by 52
Self-citationHara, T., Higashi, T., Nakamoto, Y., Suga, T., Saga, T., Ishimori, T., Ishizu, K., Kawashima, H., Kawase, S., Matsumoto, K., et al. (2009) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0288-7 · Cited by 40
“In addition, Zhao et al. reported in their animal model that insulin loading decreased the FDG uptake into tumors, while glucose loading did not [ 4 ].”
BackgroundTurcotte, É. E., Leblanc, M., Carpentier, A. C., & Bénard, F. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0064-1 · Cited by 43
“[17], using a rodent model, compared the effect of insulin injection alone versus glucose administration on the uptake of tumors as well as at the sites of sterile and bacterial inflammation.”
Takei, T., Kuge, Y., Zhao, S., Sato, M., Strausś, H. W., Blankenberg, F. G., Tait, J. F., & Tamaki, N. (2005) · PubMed · Cited by 38
Self-citationBucerius, J. A., Dijkgraaf, I., Mottaghy, F. M., & Schurgers, L. J. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4176-z · Cited by 35
Takei, T., Kuge, Y., Zhao, S., Sato, M., Strausś, H. W., Blankenberg, F. G., Tait, J. F., & Tamaki, N. (2004) · PubMed · Cited by 32
Self-citationZhao, S., Kuge, Y., Kohanawa, M., Takahashi, T., Kawashima, H., Temma, T., Takei, T., Zhao, Y., Seki, K., & Tamaki, N. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0529-8 · Cited by 25
“aureus and turpentine oil showed levels of FDG uptake which were about 45% and 34% of that in KDH-8 tumor, respectively [6].”
BackgroundMethodSelf-citationAn autoradiographic study of [18F]FDG uptake to islets of Langerhans in NOD mouse
Kalliokoski, T., Simell, O., Haaparanta‐Solin, M., Viljanen, T., Solin, O. H., Knuuti, J. M., & Nuutila, P. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.04.008 · Cited by 22
Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
Chang, Y.-C., Yen, T., Ng, K., See, L., Lai, C., Chang, T., Tsai, C.-S., Hong, J., Hsueh, S., & Chou, H. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1744-1 · Cited by 20
Singer, E., Gschwantler, M., Plattner, D., Kriwanek, S., Armbruster, C., Schueller, J., Feichtinger, H. G., Roka, R., Moeschl, P., Weiss, W. H., et al. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328011741d · Cited by 18
Buettner, C., Rudd, J. H. F., & Fayad, Z. A. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.09.011 · Cited by 17
Wyss, M. T., Honer, M., Spaeth, N., Gottschalk, J., Ametamey, S. M., Weber, B., von Schulthess, G. K., Buck, A., & Kaim, A. H. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.06.001 · Cited by 18
Hess, S., Scholtens, A. M., & Gormsen, L. C. (2020) · PET Clinics · doi:10.1016/j.cpet.2019.11.001 · Cited by 17
“compared FDG-uptake relative in malignant cells, Staphylococcus aureus infection, and aseptic turpentine induced inflammation in a rat model; FDG-uptake was 2-3-fold higher in malignant cells compared to both types of inflammation in euglycemic and euinsulinemic controls, whereas uptake decreased significantly in mali…”
ResultPijl, J. P., Glaudemans, A. W. J. M., Gheysens, O. S., Slart, R. H. J. A., & Kwee, T. C. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264839 · Cited by 15
Inflammatory imaging with ultrasmall superparamagnetic iron oxide
Matsushita, T., Kusakabe, Y., Fujii, H., Murase, K., Yamazaki, Y., & Murase, K. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.08.005 · Cited by 15
“Recent investigations, however, have demonstrated that FDG accumulates not only in malignant tumors but also in inflammatory tissues [4–13].”
BackgroundZhao, J., Tan, C., Imai, R., Ukon, N., Shimoyama, S., Maejima, Y., Omiya, Y., Takahashi, K., Ito, H., Nan, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86825-8 · Cited by 17
Self-citationZhao, S., Kuge, Y., Yi, M., Zhao, Y., Hatano, T., Magota, K., Nishijima, K., Kohanawa, M., & Tamaki, N. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1865-2 · Cited by 15
“Immunohistochemical staining was also carried out using the adjacent sections, in accordance with a standard immunostaining procedure [24].”
MethodSelf-citationHamazawa, Y., Koyama, K., Okamura, T., Wada, Y., Wakasa, T., Okuma, T., Watanabe, Y., & Inoue, Y. (2007) · Annals of Nuclear Medicine · doi:10.1007/bf03033999 · Cited by 13
Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
Mirpour, S., Meteesatien, P., & Khandani, A. H. (2011) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2011.05.006 · Cited by 13
Emerging diagnostic and therapeutic molecular imaging applications in vascular disease
Eraso, L. H., Reilly, M. P., Sehgal, C. M., & Mohler, E. R. (2011) · Vascular Medicine · doi:10.1177/1358863x10392474 · Cited by 14
Hustinx, R., & Malaise, M. (2006) · PET Clinics · doi:10.1016/j.cpet.2006.02.003 · Cited by 12
Sharma, P., Chatterjee, P., Alvarado, L. A., & Dwivedi, A. K. (2022) · Nuclear Medicine Review · doi:10.5603/nmr.a2022.0036 · Cited by 10
Pancreatic Glucose Uptake in Vivo in Men with Newly Diagnosed Type 1 Diabetes
Kalliokoski, T., Nuutila, P., Virtanen, K. A., Iozzo, P., Bucci, M., Svedström, E., Roivainen, A., Någren, K., Viljanen, T., Minn, H. R. I., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2533 · Cited by 11
Suzuki, M., Yamaguchi, K., Honda, G., Iwata, R., Furumoto, S., Jeong, M.-G., Fukuda, H., & Itoh, M. (2005) · Annals of Nuclear Medicine · doi:10.1007/bf02985052 · Cited by 10
Chung, K. H., Park, J. K., Lee, S. H., Hwang, D. W., Cho, J. Y., Yoon, Y., Han, H., & Hwang, J. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.06.038 · Cited by 9
Song, H.-S., Yoon, J., Lee, S. J., Yoon, S.-H., Jo, K.-S., & An, Y. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32836066a2 · Cited by 8
Effect of steroids on [18F]fluorodeoxyglucose uptake in an experimental tumour model
Zhao, S., Kuge, Y., Nakada, K., Mochizuki, T., Takei, T., Okada, F., & Tamaki, N. (2004) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000126512.26835.27 · Cited by 8
Self-citationGeiger, K. R., Pasvolsky, O., Berger, T., Raanani, P., Shochat, T., Gurion, R., Anati, T., Groshar, D., Gafter‐Gvili, A., & Bernstine, H. (2022) · EJNMMI Research · doi:10.1186/s13550-022-00924-9 · Cited by 8
Management of hyperglycemia in oncological patients scheduled for an FDG-PET/CT examination
Evangelista, L., Gori, S., Rubini, G., & Gallo, M. (2019) · Clinical and Translational Imaging · doi:10.1007/s40336-019-00347-y · Cited by 9
PET Radiochemistry and Radiopharmacy
Jacobson, M., Steichen, R. A., & Peller, P. J. (2012) · Medical radiology · doi:10.1007/174_2012_703 · Cited by 5
“The increased expression of GLUT receptors and elevated hexokinase activity in activated leukocytes is very similar to tumor cells (Zhao et al. 2001; Higashi et al. 2002).”
BackgroundZhao, S., Kuge, Y., Zhao, Y., Takeuchi, S., Hirata, K., Takei, T., Shiga, T., Dosaka‐Akita, H., & Tamaki, N. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-525 · Cited by 5
“Immunohistochemical stainings of EGFR and Ki-67 (a tumor cell proliferation marker) was carried out using adjacent sections, in accordance with a standard procedure [32].”
Self-citationSun, Y.-L., Jan, M., Fan, K., Lee, T., Kao, P., Hsu, H., Chang, W., & Shen, Y. (2005) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70198-6 · Cited by 5
“Recent investigations, however, have demonstrated that inflammatory cells such as macrophages and neutrophils also use increased amounts of glucose during chemotaxis and phagocytosis, which can be clearly visualized in vivo at the site of inflammation and infection [8].”
BackgroundNUCLEAR (SCINTIGRAPHIC) METHODS AND FDG-PET IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
Ribbens, C., & Hustinx, R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4722-3.00007-0 · Cited by 4
Infectious and Inflammatory Diseases
Lee, K.-H., & Chung, J. (2004) · Springer eBooks · doi:10.1007/978-0-387-22530-2_13 · Cited by 4
Liang, M., Du, Y., Zhaoyu, L., Shanshi, L., Zhao, G., Fan, Y., Xiuying, Y., & Jianhua, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-45094-3 · Cited by 4
“One study reported that insulin reduced FDG uptake in allogenic hepatoma cells (KDH-8) in euglycemic rats 29 .”
BackgroundDoes hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?
Mirpour, S., Meteesatien, P., & Khandani, A. H. (2012) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2012.03.007 · Cited by 3
dos Anjos, D. A., & da Mota, L. M. H. (2014) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2014.07.003 · Cited by 2
Mulier, J. L. G. H., van Leer, B., Beijer-Verduin, J. J., de Grooth, H., Lavalaye, J., Noordzij, P. G., Pater, N., Pool, S. E., Rettig, T. C. D., van Stee, C. P., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06005-w · Cited by 1
“Both elevated blood glucose and insulin administration alter FDG bio-distribution in skeletal and cardiac muscle, resulting in lower image quality and consequently lower sensitivity [19, 20].”
dos Anjos, D. A., & da Mota, L. M. H. (2014) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2014.07.002 · Cited by 1
Various Aspects of Fasting on the Biodistribution of Radiopharmaceuticals
Ahmadpour, S., Habibi, M. A., & Hosseinimehr, S. J. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220919121354 · Cited by 1
Zhao, J., Imai, R., Ukon, N., Shimoyama, S., Tan, C., Maejima, Y., Omiya, Y., Takahashi, K., Nan, G., Zhao, S., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.657663 · Cited by 1
“, insulin shifts 18F-FDG from the original area to insulin-sensitive organs (40, 41).”
BackgroundSelf-citationSha, W. (2012) · eScholarship (California Digital Library) · Cited by 2
Anatomical and Physiological Variants
Santiago, J. F. Y. (2014) · Springer eBooks · doi:10.1007/978-3-319-05518-3_9
Tomographie a emission de positons : vers une approche plus specifique des pathologies oncologiques
Hustinx, R. (2003) · ORBi (University of Liège)
Management of blood glucose levels in oncological patients scheduled for FDG PET/CT examination
Evangelista, L. S. (2019) · The Journal of AMD · doi:10.36171/jamd19.22.4.08
“Unnecessary interventions aimed at lowering BGLs are sometimes timeand resources-consuming, including insulin injection, also with a potential decrease of PET scan sensitivity due to a greater muscle uptake of FDG (1).”
BackgroundFernandes, G., Moryoussef, M., Dufour, I., Lhommel, R., & Goffin, E. (2026) · Peritoneal Dialysis International · doi:10.1177/08968608251412166
Zadeh, M. Z. (2026) · Annals of Nuclear Medicine · doi:10.1007/s12149-026-02228-7
“Non-commercial uses include articles in peer-review journals, class - room/teaching material, and academic theses/dissertations tumor cells while increasing background soft-tissue activity, leading to suboptimal image quality and reduced diagnostic reliability [21, 22].”
Tomczyk, M. D., Wawrzynosek, C., de Carrillo, D. G., Krzystanek, M., Pantziarka, P., & Jędrzejowska–Szypułka, H. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119009 · Cited by 1
Metadata
- Authors
- Zhao, S., Kuge, Y., Tsukamoto, E., Mochizuki, T., Kato, T., Hikosaka, K., Hosokawa, M., Kohanawa, M., & Tamaki, N.
- Affiliations
- Hokkaido University (JP)
- Nikko Memorial Hospital (JP)
- Corresponding author
- Kuge, Yuji
- Venue
- European Journal of Nuclear Medicine
- Published
- 2001-06
- Volume
- 28
- Issue
- 6
- Pages
- 730-735
- ISSN
- 1619-7070 (ISSN-L)
- 0340-6997
- 1619-7089
- OpenAlex
- W1561754985
- Cited by
- 68
- References
- 32
- Citations by year
- 2026: 5 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- insulin, glucose load, hypoglycemia, hyperglycemia, cancer, inflammatory lesions, FDG-PET, Staphylococcus aureus infection, turpentine-induced inflammation, rats, tumor glucose metabolism
- MeSH terms
- Animals, Blood Glucose, Glucose, Hypoglycemic Agents, Inflammation, Insulin, Liver Neoplasms, Experimental, Male, Neoplasm Transplantation, Radionuclide Imaging, Staphylococcal Infections, Tissue Distribution, Rats, Wistar, Radiopharmaceuticals, Fluorodeoxyglucose F18, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.